Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ibn Sina Pharmaceutical Industry PLC is a leading pharmaceutical manufacturer based in Bangladesh and a key subsidiary of the Ibn Sina Trust. Established in 1983, the company produces a wide range of generic medicines, including solid dosages, liquid vitals, and natural (herbal and Unani) medicines. The company operates state-of-the-art manufacturing facilities in Gazipur and Munshiganj that comply with WHO cGMP standards and are equipped for specialized production such as cephalosporins. Ibn Sina is publicly listed on the Dhaka and Chittagong stock exchanges and has a growing international presence, exporting products to over 15 countries. The company is integral to the broader Ibn Sina healthcare network, which includes several specialized hospitals and diagnostic centers across Bangladesh.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ibn Sina Hospital.